Stay updated with breaking news from Rog Eb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Andrea Figueras Roche said that it has received positive long-term follow-up data and significant overall survival benefit from the Katherine study, which...
By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing...
By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The...
Supreme Court case puts focus on wealth taxes, IBM and Meta form group to support open approach to AI, more pharmas seek a stake in weight-loss market, and...
Pfizer expects the market for new obesity pills to be $90 billion per year. Lilly, Novo, and many biotechs hope to claim chunks of it.